EN
HI
Summary
As of 12 Sep, 2026, Brooks Laboratories stock price is ₹65.69. During the trading session, the stock has moved between an intraday low of ₹63.12 and an intraday high of ₹69.72. Over the last 52 weeks, Brooks Laboratories has traded between ₹36.30 and ₹163.90.
The stock has recorded a trading volume of 1,01,530 shares,. Its Average Traded Price (ATP) is ₹66.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 200 @ ₹65.69.
Brooks Laboratories has an upper circuit limit of ₹70.23 and a lower circuit limit of ₹57.47. The total value traded stands at ₹67.74 L, and the delivery percentage for the day is 27.54%.
The stock is currently traded with a market lot size of 1. Brooks Laboratories also offers a dividend yield of 0%.
Brooks Laboratories Share Price Chart
Brooks Laboratories Share Key Metrics
Volume
1.02 L
Market Cap
193.50 CR
LTQ@LTP
200@65.69
ATP
66.72
Var Margin
29.96 %
Circuit Range
57.47-70.23
Delivery %
27.54 %
Value
67.74 L
ASM/GSM
No
Market Lot
1
Brooks Laboratories Fundamentals
P/E Ratio
14.17
P/B Ratio
1.51
Div. Yield
0
Sector P/E
41.56
Sector P/B
3.6
Sec. Div. Yield
0.5
Brooks Laboratories Resistance and Support
Pivot 64.32
Resistance
First Resistance
65.54
Second Resistance
67.22
Third Resistance
68.44
Support
First Support
62.64
Second Support
61.42
Third Support
59.74
Brooks Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 64.7 | 65.69 | 2.90% | 69.72 | 63.12 |
| Thu Sep 10 2026 | 66 | 63.84 | 1.35% | 66 | 63.09 |
| Wed Sep 09 2026 | 64.61 | 62.99 | -0.47% | 65.5 | 61.15 |
Brooks Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-02-13 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Brooks Laboratories News
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026
Brooks Laboratories approved its Q1 FY27 results, reporting a standalone net profit of ₹1.42 crores. The company posted a consolidated net loss of ₹1.79 crores, a significant reversal from the previous year's profit, largely due to a ₹3.21 crore loss from its jointly controlled entity, Brooks Steriscience Limited.
Aug 13 2026 19:50:11
Brooks Laboratories Management
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary & Compliance Officer |
| Bhushan Singh Rana | Whole Time Director |
Brooks Laboratories Similar Stocks
Brooks Laboratories FAQs
The Buying Price of Brooks Laboratories share is 65.69 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brooks Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brooks Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brooks Laboratories shares is 14.17. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brooks Laboratories shares is 1.51. Useful to assess the stock's value relative to its book value.
To assess Brooks Laboratories’s valuation compare Sector P/E, P/B which are 41.56 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brooks Laboratories is 193.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brooks Laboratories share price is 163.90 & 36.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brooks Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BROOKS
